Advantage Alpha Capital Partners LP lessened its holdings in Blend Labs, Inc. (NYSE:BLND – Free Report) by 35.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 563,716 shares of the company’s stock after selling 303,782 shares during the quarter. Advantage Alpha Capital Partners LP owned 0.22% of Blend Labs worth $2,373,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of the stock. Principal Financial Group Inc. raised its stake in Blend Labs by 697.6% in the 3rd quarter. Principal Financial Group Inc. now owns 2,733,004 shares of the company’s stock worth $10,249,000 after purchasing an additional 2,390,337 shares in the last quarter. State Street Corp lifted its position in shares of Blend Labs by 57.6% in the 3rd quarter. State Street Corp now owns 5,461,973 shares of the company’s stock worth $20,482,000 after purchasing an additional 1,995,362 shares during the period. Summit Partners Public Asset Management LLC grew its stake in Blend Labs by 452.7% during the third quarter. Summit Partners Public Asset Management LLC now owns 1,895,865 shares of the company’s stock worth $7,109,000 after purchasing an additional 1,552,865 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Blend Labs by 193.5% during the third quarter. JPMorgan Chase & Co. now owns 1,714,955 shares of the company’s stock valued at $6,431,000 after purchasing an additional 1,130,706 shares during the period. Finally, Royce & Associates LP bought a new position in shares of Blend Labs in the 4th quarter worth $3,406,000. 52.56% of the stock is currently owned by institutional investors.
Blend Labs Price Performance
BLND opened at $3.66 on Monday. The business has a 50 day simple moving average of $3.64 and a two-hundred day simple moving average of $3.97. Blend Labs, Inc. has a one year low of $2.08 and a one year high of $5.53. The firm has a market capitalization of $935.42 million, a price-to-earnings ratio of -10.75 and a beta of 1.40.
Insider Transactions at Blend Labs
Wall Street Analysts Forecast Growth
BLND has been the subject of a number of recent analyst reports. UBS Group reduced their price objective on Blend Labs from $4.00 to $3.50 and set a “neutral” rating for the company in a research note on Friday, February 28th. Keefe, Bruyette & Woods cut their price target on Blend Labs from $3.85 to $3.50 and set a “market perform” rating for the company in a report on Monday, March 3rd. Citizens Jmp upgraded shares of Blend Labs to a “strong-buy” rating in a research note on Wednesday, December 18th. JMP Securities assumed coverage on Blend Labs in a report on Wednesday, December 18th. They set an “outperform” rating and a $7.00 price objective for the company. Finally, Wells Fargo & Company raised their price target on Blend Labs from $4.50 to $6.50 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $4.91.
Get Our Latest Research Report on Blend Labs
Blend Labs Company Profile
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Featured Articles
- Five stocks we like better than Blend Labs
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Canadian Penny Stocks: Can They Make You Rich?
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Most active stocks: Dollar volume vs share volume
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding BLND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Blend Labs, Inc. (NYSE:BLND – Free Report).
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.